Finance

Lists
688399:SHA
Jiangsu Bioperfectus Technologies Co Ltd
24,15 CNY
-0,98%
(-0,24) 1D
16 ოქტ, 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688399...
Open
24,63 CNY
High
25,68 CNY
Low
23,93 CNY
Mkt. cap
3,27 მლრდ.
Avg. vol.
2,11 მლნ.
Volume
2,40 მლნ.
52-wk high
63,51 CNY
52-wk low
23,24 CNY
EPS
-0,21 CNY
No. of employees
578
Open
24,63 CNY
High
25,68 CNY
Low
23,93 CNY
Mkt. cap
3,27 მლრდ.
Avg. vol.
2,11 მლნ.
Volume
2,40 მლნ.
52-wk high
63,51 CNY
52-wk low
23,24 CNY
EPS
-0,21 CNY
No. of employees
578
News stories
From web sources and news partners
Fierce Biotech
Fierce Biotech
·
2 საათის წინ
City goes public with $200M IPO, while Frazier Life Sciences takes biotech-focused SPAC to Nasdaq
Simply Wall Street
Simply Wall Street
·
35 წუთის წინ
Pega Stock Gets Analyst Backing Ahead Of Results
Investor's Business Daily
Investor's Business Daily
·
6 საათის წინ
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
Yahoo Finance
Yahoo Finance
·
3 საათის წინ
XRP Treasury Company Evernorth Just Went Public on Nasdaq. Here's How It Could Impact the Price of XRP.
About Jiangsu Bioperfectus Technologies Co Ltd
CEO-
Employees578
Founded12 აპრ. 2010
HeadquartersTaizhou, Jiangsu, ჩინეთი
SectorMedical device
Websites-sbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
81,93 მლნ.
81,54 მლნ.
78,58 მლნ.
68,84 მლნ.
Cost of goods sold
21,15 მლნ.
54,23 მლნ.
32,44 მლნ.
24,38 მლნ.
Cost of revenue
21,15 მლნ.
54,23 მლნ.
32,44 მლნ.
24,38 მლნ.
Research and development expenses
21,10 მლნ.
16,81 მლნ.
14,86 მლნ.
17,40 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47,17 მლნ.
68,11 მლნ.
39,23 მლნ.
45,24 მლნ.
Operating expense
51,56 მლნ.
87,10 მლნ.
34,29 მლნ.
57,94 მლნ.
Total operating expenses
72,71 მლნ.
141,33 მლნ.
66,73 მლნ.
82,32 მლნ.
Operating income
9,21 მლნ.
-59,79 მლნ.
11,85 მლნ.
-13,48 მლნ.
Other non operating income
-141,76 ათ.
48,38 ათ.
-510,55 ათ.
345,35 ათ.
EBT including unusual items
112,52 ათ.
-39,18 მლნ.
26,66 მლნ.
48,94 ათ.
EBT excluding unusual items
9,80 მლნ.
-59,00 მლნ.
11,32 მლნ.
-12,83 მლნ.
Income tax expense
953,48 ათ.
5,05 მლნ.
5,54 მლნ.
1,61 მლნ.
Effective tax rate
847,35%
-12,88%
20,78%
3 282,90%
Other operating expenses
-9,32 მლნ.
6,02 მლნ.
-2,04 მლნ.
-917,54 ათ.
Net income
-840,95 ათ.
-44,23 მლნ.
21,12 მლნ.
-1,56 მლნ.
Net profit margin
-1,03%
-54,24%
26,88%
-2,26%
Earnings per share
-
-
-
-
Interest and investment income
1,91 მლნ.
3,58 მლნ.
1,95 მლნ.
3,97 მლნ.
Interest expense
-1,31 მლნ.
-2,21 მლნ.
-1,97 მლნ.
-2,54 მლნ.
Net interest expenses
598,67 ათ.
1,36 მლნ.
-20,48 ათ.
1,43 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
21,55 მლნ.
-47,57 მლნ.
24,08 მლნ.
-1,50 მლნ.
Gain or loss from assets sale
329,46 ათ.
-102,43 ათ.
-
-535,02 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები